MTOR and pancreatic neoplasm: miR-373 regulates MMP activity by modulating MAPK signaling or targeting mTOR and SIRT1 in human fibrosarcoma cells (Fan et al., 2013), and by targeting ZIP4 in pancreatic cancer (Liu & Wilson, 2012).